Supreme Court Rejects J&J Bid to Overturn $302M Vaginal Mesh Lawsuit Award
The Supreme Court has denied a Johnson & Johnson petition to review a $302 million verdict won by the state of California over the company's marketing of its vaginal mesh…
The Supreme Court has denied a Johnson & Johnson petition to review a $302 million verdict won by the state of California over the company's marketing of its vaginal mesh…
After reviewing the final postmarketing study on Coloplast transvaginal mesh, the FDA has determined the risks still outweigh the potential benefits.
A Boston Scientific vaginal mesh lawsuit claims the Obtryx II mesh is defectively designed, leading to unreasonable health risks for patients.
A transvaginal mesh lawsuit has been filed over an Ethicon Gynecare mesh which eroded through a woman's flesh
New postmarketing surveillance studies show Boston Scientific transvaginal mesh increase the risk of health complications for pelvic organ prolapse patients, without adding any additional effectiveness or safety over traditional surgical…
Boston Scientific will pay $187 million to resolve claims by most states that it misled both women and state health agencies over the safety and efficacy of transvaginal mesh products.
C.R. Bard will pay $60 million to resolve claims with most states that its transvaginal mesh products were deceptively advertised.
A California judge wants Johnson & Johnson to pay $344 million to the state for falsely advertising the safety of its vaginal mesh products.
Johnson & Johnson and Ethicon have agreed to pay 41 states nearly $117 million to settle charges of deceptive marketing and defrauding state health care systems over the safety and…
Two new studies provide more evidence that vaginal mesh carry few, if any, benefits, and that there is little which can be done to improve them.